PERCF (Percheron Therapeutics) Beginning Cash Position : $7.34 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Beginning Cash Position?

Percheron Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was $7.34 Mil.

Percheron Therapeutics's quarterly Beginning Cash Position declined from Dec. 2022 ($12.98 Mil) to Jun. 2023 ($11.16 Mil) and declined from Jun. 2023 ($11.16 Mil) to Dec. 2023 ($7.34 Mil).

Percheron Therapeutics's annual Beginning Cash Position increased from Jun. 2021 ($3.10 Mil) to Jun. 2022 ($4.23 Mil) and increased from Jun. 2022 ($4.23 Mil) to Jun. 2023 ($12.91 Mil).

Percheron Therapeutics Beginning Cash Position Historical Data

The historical data trend for Percheron Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Beginning Cash Position Chart

Percheron Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

Get a 7-Day Free Trial

2.00

3.10

4.23

12.91

7.28

Percheron Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															16.50	12.98	11.16	7.34	11.42

Percheron Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Percheron Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

AWY0:Germany AWY0:Germany PER:Australia

Address

14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142

Website

https://www.percherontx.com

Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.